MEG Medical Equipment GmbH (MEG), an international supplier of medical aids, has been sold to Dutch private equity investor Gilde Healthcare. GÖRG advised Dutch shareholder De Baron B.V. from Gendt on the transaction. The parties have agreed not to disclose the purchase price. 

One of the sellers of MEG was Harald Quandt Industriebeteiligungen GmbH (HQIB), the largest shareholder. Together with other shareholders, including the Dutch company De Baron B.V., the shareholders organised the sale process. De Baron most recently held a stake of around 15 per cent in MEG and had sold its operating business to the group several years earlier.

With the acquisition by Gilde Healthcare, MEG is continuing its international growth course and expanding its range to include innovative medical products and digital solutions for the care sector. The company is one of Europe's leading suppliers of specialised medical aids for the prevention and treatment of pressure ulcers. In addition to the German manufacturer Funke Medical, which belongs to the group, MEG also includes the Dutch company Deron B.V., which was previously brought into the group by De Baron.

A GÖRG team led by Dr Stefan Heyder provided comprehensive legal advice to De Baron B.V. on the sale. The advice included assisting De Baron B.V. in the negotiation of numerous contracts and corporate agreements. The notarisation and closing took place on 13 November 2025 in Frankfurt am Main.

Advisors De Baron B.V.

GÖRG Partnerschaft von Rechtsanwälten mbB 
Dr Stefan Heyder (Lead, Partner, Corporate Law/M&A, Munich)
Moritz von Limburg (Senior Associate, Corporate Law/M&A, Munich)
Philipp Albert (Associate, Corporate Law/M&A, Frankfurt am Main)